Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome.
Kwon
Theresa
T
Pediatric Nephrology, Hôpital Robert Debré, Paris, France. theresa.kwon@rdb.aphp.fr
Dragon-Durey
Marie-Agnes
MA
Macher
Marie-Alice
MA
Baudouin
Veronique
V
Maisin
Anne
A
Peuchmaur
Michel
M
Fremeaux-Bacchi
Veronique
V
Loirat
Chantal
C
D001323:Autoantibodies / Q000276:immunology*; D001707:Biopsy, Needle; D002648:Child; D003131:Combined Modality Therapy; D017242:Complement Factor H / Q000276:immunology*; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006463:Hemolytic-Uremic Syndrome / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000379:methods; D010956:Plasmapheresis / Q000379:methods; D011182:Postoperative Care / Q000379:methods; D011300:Preoperative Care / Q000379:methods; D006435:Renal Dialysis / Q000379:methods; D018570:Risk Assessment; D012720:Severity of Illness Index; D014181:Transplantation Immunology; D016896:Treatment Outcome; D016482:Urinalysis
D001323:Autoantibodies; D007166:Immunosuppressive Agents; D017242:Complement Factor H